Quadrant Capital Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,262
| Closed | -$121K | – | 2111 |
|
|
2025
Q1 | $121K | Buy |
4,262
+1,742
| +69% | +$49.4K | ﹤0.01% | 1482 |
|
|
2024
Q4 | $105K | Buy |
2,520
+697
| +38% | +$29K | 0.01% | 1028 |
|
|
2024
Q3 | $122K | Sell |
1,823
-1,508
| -45% | -$101K | 0.01% | 958 |
|
|
2024
Q2 | $396K | Buy |
3,331
+415
| +14% | +$49.3K | 0.03% | 388 |
|
|
2024
Q1 | $311K | Buy |
2,916
+244
| +9% | +$26K | 0.02% | 455 |
|
|
2023
Q4 | $266K | Buy |
2,672
+187
| +8% | +$18.6K | 0.02% | 485 |
|
|
2023
Q3 | $257K | Buy |
2,485
+697
| +39% | +$72K | 0.03% | 429 |
|
|
2023
Q2 | $217K | Sell |
1,788
-438
| -20% | -$53.2K | 0.02% | 479 |
|
|
2023
Q1 | $342K | Sell |
2,226
-465
| -17% | -$71.4K | 0.04% | 357 |
|
|
2022
Q4 | $483K | Buy |
2,691
+986
| +58% | +$177K | 0.05% | 242 |
|
|
2022
Q3 | $202K | Sell |
1,705
-192
| -10% | -$22.7K | 0.03% | 427 |
|
|
2022
Q2 | $271K | Sell |
1,897
-38
| -2% | -$5.43K | 0.04% | 346 |
|
|
2022
Q1 | $333K | Buy |
1,935
+213
| +12% | +$36.7K | 0.04% | 323 |
|
|
2021
Q4 | $437K | Sell |
1,722
-47
| -3% | -$11.9K | 0.05% | 243 |
|
|
2021
Q3 | $681K | Buy |
1,769
+299
| +20% | +$115K | 0.1% | 151 |
|
|
2021
Q2 | $345K | Buy |
1,470
+134
| +10% | +$31.4K | 0.05% | 253 |
|
|
2021
Q1 | $175K | Buy |
1,336
+288
| +27% | +$37.7K | 0.03% | 389 |
|
|
2020
Q4 | $109K | Buy |
1,048
+423
| +68% | +$44K | 0.02% | 470 |
|
|
2020
Q3 | $44K | Buy |
625
+55
| +10% | +$3.87K | 0.01% | 701 |
|
|
2020
Q2 | $37K | Sell |
570
-1,225
| -68% | -$79.5K | 0.01% | 836 |
|
|
2020
Q1 | $54K | Buy |
+1,795
| New | +$54K | 0.01% | 851 |
|